The fibrosis puzzle of systemic sclerosis-associated ILD and the quest for targeted interventions
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality in systemic sclerosis, marked by complex immunopathogenic mechanisms and progressive fibrosis. Recent advances have illuminated key cellular players as T cells, macrophages, dendritic cell...
Saved in:
| Main Authors: | Bohdana Doskaliuk, Liubomyr Zaiats, Nazar Sahan, Yuliya Fedorchenko, Olga Antymys, Roman Yatsyshyn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666251366023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
by: Anna-Maria Hoffmann-Vold, et al.
Published: (2020-09-01) -
PHOTOTHERAPY: CUTANEOUS AND SYSTEMIC REJUVENATION
by: Bohdana Doskaliuk
Published: (2025-06-01) -
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?
by: Francesco Amati, et al.
Published: (2025-06-01) -
European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD).
by: Ekaterina Krauss, et al.
Published: (2025-01-01) -
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
by: Hiroaki Fujii, et al.
Published: (2023-01-01)